OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4
Mingying Li, Jingjing Ye, Xia Yuan, et al.
Leukemia (2022) Vol. 36, Iss. 11, pp. 2586-2595
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 60

The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 32

Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18

Advances in targeting RNA modifications for anticancer therapy
Monica Pomaville, Chuan He
Trends in cancer (2023) Vol. 9, Iss. 7, pp. 528-542
Open Access | Times Cited: 30

Small molecule inhibitors targeting m6A regulators
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 12

Immunotherapeutic targeting of surfaceome heterogeneity in AML
Marie-Ève Bordeleau, Éric Audemard, Arnaud Métois, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114260-114260
Open Access | Times Cited: 10

Human immune organoids to decode B cell response in healthy donors and patients with lymphoma
Zhong Zhe, Manuel Quiñones-Pérez, Zhonghao Dai, et al.
Nature Materials (2024)
Closed Access | Times Cited: 9

Suppression of the METTL3-m6A-integrin β1 axis by extracellular acidification impairs T cell infiltration and antitumor activity
Zhe Wang, Jingzhe Shang, Yajing Qiu, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113796-113796
Open Access | Times Cited: 8

Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia
Shengnan Guo, Gopi S. Mohan, Bofei Wang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008318-e008318
Open Access | Times Cited: 5

HDAC1/3-dependent moderate liquid–liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation
Meng Li, Mingying Li, Xia Yuan, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 20

The relevance of the hematopoietic niche for therapy resistance in acute myeloid leukemia
Catana Allert, Carsten Müller‐Tidow, Maximilian Felix Blank
International Journal of Cancer (2023) Vol. 154, Iss. 2, pp. 197-209
Open Access | Times Cited: 12

Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4225-4225
Open Access | Times Cited: 11

Comprehensive analysis of m6A methylome alterations after azacytidine plus venetoclax treatment for acute myeloid leukemia by nanopore sequencing
Zaifeng Zhang, Lili Zhang, Jiangtao Li, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1144-1153
Open Access | Times Cited: 4

Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4

Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT/mTOR
Shuling Zhang, Lanxia Zhou, Jincai Yang, et al.
Anti-Cancer Drugs (2024)
Closed Access | Times Cited: 4

Targeting METTL3 mitigates venetoclax resistance via proteasome-mediated modulation of MCL1 in acute myeloid leukemia
Cheng Jiao, Chen Hu, Meng-Hua Sun, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access

Summary of the mechanism of ferroptosis regulated by m6A modification in cancer progression
Bin Fan, Gangxian Chen, Shu‐Yi Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Machine learning approaches reveal methylation signatures associated with pediatric acute myeloid leukemia recurrence
Yushuang Dong, HuiPing Liao, FeiMing Huang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Interpreting single-cell messages in normal and aberrant hematopoiesis with the Cell Marker Accordion
Emma Busarello, Giulia Biancon, Ilaria Cimignolo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

A new perspective on hematological malignancies: m6A modification in immune microenvironment
Shiyu Yang, Liping Xu, Haihui Zhuang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top